3-(1-Oxoisoindolin-2-yl)propanoic acid finds application in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. It is particularly useful in the development of drugs targeting neurological disorders, such as epilepsy and anxiety, due to its structural similarity to compounds that interact with neurotransmitter systems. Additionally, it serves as a building block in the creation of small molecules for cancer research, where its derivatives are explored for their potential anti-tumor properties. In medicinal chemistry, it is employed to design and optimize drug candidates with improved efficacy and reduced side effects. Its versatile structure also makes it valuable in the synthesis of complex organic molecules for further pharmacological studies.